Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Outset Medical Inc

OM
Current price
11.58 USD +0.72 USD (+6.63%)
Last closed 11.25 USD
ISIN US6901451079
Sector Healthcare
Industry Medical Devices
Exchange NASDAQ
Capitalization 192 460 912 USD
Yield for 12 month -70.65 %
1Y
3Y
5Y
10Y
15Y
OM
21.11.2021 - 28.11.2021

Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also provides Tablo Data Ecosystem, including TabloHub, a customer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California. Address: 3052 Orchard Drive, San Jose, CA, United States, 95134

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

21.75 USD

P/E ratio

Dividend Yield

Current Year

+113 689 000 USD

Last Year

+130 376 000 USD

Current Quarter

+29 467 000 USD

Last Quarter

+28 666 000 USD

Current Year

+38 564 000 USD

Last Year

+29 000 000 USD

Current Quarter

+10 747 000 USD

Last Quarter

+9 820 000 USD

Key Figures OM

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -102 092 000 USD
Operating Margin TTM -55.33 %
Price to Earnings
Return On Assets TTM -22.86 %
PEG Ratio
Return On Equity TTM -170.97 %
Wall Street Target Price 21.75 USD
Revenue TTM 113 689 000 USD
Book Value 7.60 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -3.40 %
Dividend Yield
Gross Profit TTM 39 143 000 USD
Earnings per share -36.90 USD
Diluted Eps TTM -36.90 USD
Most Recent Quarter IV 2024
Quarterly Earnings Growth YOY
Profit Margin -112.57 %

Dividend Analytics OM

Max Ratio

>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Dividend History OM

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Ex Dividend Date
Dividend CAGR 3Y
Dividend CAGR 5Y
Dividend CAGR 10Y
Consecutive Years
Consistent Years
Continuous Dividends
Forward Annual Dividend Yield
Forward Annual Dividend – USD
Last Split Factor 1:15
Payout Ratio TTM
Last Split Date 20.03.2025

Stock Valuation OM

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 2.07
Price Sales TTM 1.69
Enterprise Value EBITDA -0.24
Price Book MRQ 7.18

Financials OM

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators OM

For 52 weeks

5.85 USD 78.30 USD
50 Day MA 10.77 USD
Shares Short Prior Month 11 817 649
200 Day MA 16.59 USD
Short Ratio 8.45
Shares Short 876 793
Short Percent 4.97 %